Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.

Integrating oncolytic viruses in combination cancer immunotherapy

Bommareddy, Praveen K., Shettigar, Megha, Kaufman, Howard L. · 2018 · Nature reviews. Immunology

Abstract

Oncolytic viruses can be usefully integrated into tumour immunotherapies, as they target multiple steps within the cancer-immunity cycle. Oncolytic viruses directly lyse tumour cells, leading to the release of soluble antigens, danger signals and type I interferons, which drive antitumour immunity. In addition, some oncolytic viruses can be engineered to express therapeutic genes or can functionally alter tumour-associated endothelial cells, further enhancing T cell recruitment into immune-excluded or immune-deserted tumour microenvironments. Oncolytic viruses can also utilize established tumours as an in situ source of neoantigen vaccination through cross-presentation, resulting in regression of distant, uninfected tumours. These features make oncolytic viruses attractive agents for combination strategies to optimize cancer immunotherapy.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41577-018-0014-6

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 147 references

Cited by

See all 704

Metadata

Authors
Bommareddy, P. K., Shettigar, M., & Kaufman, H. L.
Affiliations
  • Rutgers, The State University of New Jersey (US)
  • Dana-Farber Cancer Institute (US)
  • Massachusetts General Hospital (US)
Corresponding author
Kaufman, Howard L.
Venue
Nature reviews. Immunology
Published
2018-05-09
Volume
18
Issue
8
Pages
498-513
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
OpenAlex
W2801821552
Cited by
704
References
147
Citations by year
2026: 63 · 2025: 88 · 2024: 94 · 2023: 105 · 2022: 99 · 2021: 105 · 2020: 90 · 2019: 47 · 2018: 13
FWCI
9.25
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature reviews. Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
oncolytic viruses, cancer immunotherapy, combination therapy, cancer-immunity cycle, tumor cell lysis, type I interferon, damage-associated molecular patterns, T cell recruitment, tumor microenvironment, cross-presentation
MeSH terms
Combined Modality Therapy, Genetic Engineering, Humans, Immunity, Innate, Immunotherapy, Neoplasms, Neovascularization, Pathologic, Virus Replication, Biomarkers, Gene Expression, Cell Death, Models, Immunological, Oncolytic Virotherapy, Oncolytic Viruses, Adaptive Immunity, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrating oncolytic viruses in combination cancer immunotherapy. https://app.cochat.ai/papers/10.1038/s41577-018-0014-6
The paper
Bommareddy, P. K., Shettigar, M., & Kaufman, H. L. (2018). Integrating oncolytic viruses in combination cancer immunotherapy. Nature reviews. Immunology. https://doi.org/10.1038/s41577-018-0014-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.